Wells Fargo & Company Covetrus, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$20.69 - $20.91 $18,434 - $18,630	-891 Reduced 9.4%	8,590 $178,000
Q2 2022 Aug 12, 2022	SELL	$13.8 - $20.82 $1.77 Million - $2.66 Million	-127,965 Reduced 93.1%	9,481 $196,000
Q1 2022 May 16, 2022	SELL	$15.96 - $18.87 $549,758 - $649,996	-34,446 Reduced 20.04%	137,446 $2.31 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $20.37 $25,319 - $30,717	1,508 Added 0.89%	171,892 $3.43 Million
Q3 2021 Nov 15, 2021	SELL	$18.14 - $27.03 $984,330 - $1.47 Million	-54,263 Reduced 24.15%	170,384 $3.09 Million
Q2 2021 Aug 16, 2021	SELL	$25.24 - $30.86 $2.7 Million - $3.3 Million	-106,806 Reduced 32.22%	224,647 $6.07 Million
Q1 2021 May 13, 2021	SELL	$28.29 - $39.89 $218,511 - $308,110	-7,724 Reduced 2.28%	331,453 $9.93 Million
Q4 2020 Feb 09, 2021	BUY	$24.45 - $31.59 $1.86 Million - $2.4 Million	76,061 Added 28.91%	339,177 $9.75 Million
Q3 2020 Nov 05, 2020	BUY	$17.22 - $24.59 $1.37 Million - $1.95 Million	79,410 Added 43.23%	263,116 $6.42 Million
Q2 2020 Aug 13, 2020	SELL	$6.46 - $19.27 $181,280 - $540,754	-28,062 Reduced 13.25%	183,706 $3.29 Million
Q1 2020 May 14, 2020	BUY	$5.64 - $15.23 $1.19 Million - $3.23 Million	211,768 New	211,768 $1.72 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.